Page 23 - Bharat Biotech

Bharat Biotech gets go-ahead to conduct Phase-III trials of Covaxin

The around 28,500 people expected to enrol for the Phase-III trials would be given two doses of the investigational vaccine

Covaxin: Bharat Biotech's Covid vaccine candidate gets Phase 3 trials nod

In a statement published on its website, the panel said it recommended granting the approval after studying the firm's Phase I and II data along with 'animal challenge data in two species'

Covid-19: Bharat Biotech cuts Covaxin phase-2 clinical trial size by half

For phase-2 studies, the firm is also testing the vaccine on children above 12 years of age. In phase-1, they only tested adults.

Indian samples of global Covid-19 vaccines need to be larger: Experts

Indian players like Bharat Biotech and Zydus Cadila ready for large-scale phase-3 trials

Inhaled vaccines aim to target coronavirus at its point of invasion

Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections

Govt may allow use of Covid vaccine in emergency situations: Harsh Vardhan

Warns of spike in cases during winter; China, UAE among the few countries have allowed such authorisation

Bharat Biotech told to submit complete phase 2 data of its Covid-19 vaccine

Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its Covid-19 vaccine candidate, has been asked to submit complete data of the ongoing phase-2 trial

Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

Bharat Biotech aims at billion Covaxin doses a year, phase-3 trials in Oct

Firm also ties up with Washington University's school of medicine for intransal vaccine for Covid-19

Bharat Biotech inks deal with Washington varsity for intranasal Covid vax

Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19

Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia

India's Covid-19 tally nears 5 mn with one-fifth of total cases active

India took six months to reach the first million covid cases and it has gone from four to 4.9 million in 11 days

Bharat Biotech's Covaxin succeeds in challenge trials on Rhesus monkeys

The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey

Telangana to get priority in Bharat Biotech's Covid-19 vaccine supply: KCR

Telangana CM K Chandrashekhar Rao said his government was ensuring that Telangana, as the home state, gets priority in supply of Covid-19 vaccine as and when it is manufactured by Bharat Biotech

PGI Rohtak to start phase-2 trial of Bharat Biotech's Covid-19 vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine

Phase II clinical trials of Bharat Biotech's Covid-19 vaccine from Sept 7

These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for four days after they receive the vaccine shots

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Top headlines: Q1 earnings shrink, telcos await SC verdict on AGR and more

From auto firms planning new launches for festive season, Rajnath Singh banning import of defence items to telcos awaiting SC response of AGR dues, here are the top ness of the day

Don't want to launch Covid vaccine under pressure, says Bharat Biotech CMD

Asserts safety and quality are important and that his firm will develop a vaccine that's affordable for all